Previous close | 0.0800 |
Open | 0.0000 |
Bid | 0.0000 x N/A |
Ask | 0.0000 x N/A |
Day's range | 0.0000 - 0.0000 |
52-week range | |
Volume | |
Avg. volume | 38,773 |
Market cap | N/A |
Beta (5Y monthly) | 1.32 |
PE ratio (TTM) | N/A |
EPS (TTM) | -9.9620 |
Earnings date | 18 Apr 2024 - 22 Apr 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
PHILADELPHIA, April 04, 2024--Rite Aid Corporation (OTC: RADCQ) today announced Opill, the first daily oral contraceptive FDA-approved for purchase without a prescription, is now available in all stores. Opill is a progestin-only, daily oral contraceptive (birth control pill) that’s safe and effective when used as directed to help prevent pregnancy.
PHILADELPHIA, March 12, 2024--Rite Aid (OTC: RADCQ) today announced its partnership with food surplus tracking and donation platform Copia, as it furthers its efforts to reduce waste and make a meaningful impact in the California communities it serves. As the first retail pharmacy chain to partner with Copia, Rite Aid will donate food items leveraging Copia’s seamless surplus redistribution platform to easily track inventory, prove compliance, and record impact in real time. The platform will ma
PHILADELPHIA, March 06, 2024--Rite Aid Corporation (OTC: RADCQ) ("Rite Aid" or the "Company") today announced that it has entered into an asset purchase agreement ("APA") for the partial sale of its Health Dialog business to Carenet Health ("Carenet"), a provider of healthcare engagement, clinical support, telehealth and advocacy solutions.